Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001838114-25-000007

SVP & GENERAL COUNSEL sold 4,166 shares at $29.10 ($121,210)

From the SEC's structured data for this filing

Trades in this filing

Jimenez Freddy A. · SVP & GENERAL COUNSEL

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-04 Sale : show line 1 in the form −4,166 $29.10 $121,210 30,796 D
Open-market sales · 4,166 sh · avg $29.10 · $121,210
Loading xslF345X05/form4-12082025_091231.xml…